Search


PDF Archive search engine
Last database update: 17 May at 11:24 - Around 76000 files indexed.


Show results per page

Results for «cytokines»:


Total: 17 results - 0.011 seconds

VanElzakker-VNIH-CFS-in-press.PDF 100%

When immune cells of otherwise healthy individuals detect any peripheral infection, they release proinflammatory cytokines.

https://www.pdf-archive.com/2013/06/23/vanelzakker-vnih-cfs-in-press/

23/06/2013 www.pdf-archive.com

VanElzakker - IACFSME2014 97%

Massachusetts General Hospital Psychiatric Neuroscience, Martinos Center for Biomedical Imaging Controversies in chronic fatigue syndrome (CFS) “Given that cytokines are autocrine and paracrine communication factors, their circulating levels have little functional value and represent mostly spillover from the site of cytokine production and action.” – Dantzer et al.

https://www.pdf-archive.com/2014/03/25/vanelzakker-iacfsme2014/

25/03/2014 www.pdf-archive.com

ASH2011 poster-final 84%

Cytokines were added and cells were fixed and permeabilized after 15 minutes of stimulation.

https://www.pdf-archive.com/2011/12/07/ash2011-poster-final/

07/12/2011 www.pdf-archive.com

Treatment of Neuroinflammation in Alzheimer's Disease. 82%

M1-type microglia, which consider Aβ aggregates as pathogens, release pro-inflammatory cytokines which aid in pathogen elimination, but also damage nearby healthy neurons and glial cells (25).

https://www.pdf-archive.com/2018/01/29/treatment-of-neuroinflammation-in-alzheimer-s-disease/

29/01/2018 www.pdf-archive.com

Ambulatory Rheumatology, OA, Gout 74%

needle-shaped MSU crystals, strongly negative birefringent  Elevated leukocyte counts in the synovial fluid (effusions may appear cloudy)  Large amount of crystals produce a thick pasty or chalky joint fluid -   During an acute attack, there is a falsely low or normal serum uric acid level (because inflammatory cytokines can be uricosuric).

https://www.pdf-archive.com/2014/06/11/ambulatory-rheumatology-oa-gout/

11/06/2014 www.pdf-archive.com

Protocol Certolizumab Pegol for IC FDA changes 66%

Adalimumab increases the proportion of cells undergoing apoptosis and the level of granulocyte degranulation.44 This may not be therapeutically beneficial as IC/BPS histologically demonstrates a pancystitis with mast cell infiltration.45 A total degranulation of these inflammatory cells with the release of histamine, cytokines, and proteolytic enzymes, typical of an anaphylactic reaction, may exacerbate bladder inflammation.

https://www.pdf-archive.com/2018/01/24/protocol-certolizumab-pegol-for-ic-fda-changes/

24/01/2018 www.pdf-archive.com

Berdel 56%

Pro-Rektor (Vice President) „Forschung und Wissenschaftlicher Nachwuchs“ Westfälische Wilhelms-Universitaet Muenster, Germany Specialty Boards 1985 Innere Medizin, 1990 Haematologie, 1991 ESMO Certification Medical Oncology Fellowships 1987 – 1990 Heisenberg-Fellowship DFG Awards -Certificate of Outstanding Paper Presentation of the American Oil Chemists' Society (AOCS), AOCS National Meeting, Chicago (1983) -Farmitalia Carlo Erba Preis, AIO, Deutsche Krebsgesellschaft (1985) -Certificate of Outstanding Paper Presentation of the American Oil Chemists' Society (AOCS), AOCS National Meeting, Philadelphia (1985) -Invited lecture, the Gordon Research Conferences (Cancer Chemotherapy), Colby-Sawyer College, New London, USA (1985) -Posterpreis, Deutsche Gesellschaft für Hämatologie und Onkologie, Annual Meeting in Tübingen (1986) -Heisenberg Fellowship, Deutsche Forschungsgemeinschaft (1987) -First Poster Prize, Third International Symposium on Cytokines in Hematology, Oncology, and Immunology, Hannover (1993) -2 Poster Awards, 4.

https://www.pdf-archive.com/2016/08/29/berdel/

29/08/2016 www.pdf-archive.com

art 10.1007 s11481-013-9485-1 48%

As CB2-selective cannabinoids have been shown to inhibit T-cells in several experimental conditions, as evidenced by decreasing production of J Neuroimmune Pharmacol (2013) 8:1239–1250 the cytokines IL-2, IL-6, IFN-g, and TNF-α, inhibiting migration of T-cells to inflammatory stimuli, and inhibiting proliferation of T-cells (Borner et al.

https://www.pdf-archive.com/2015/01/23/art-10-1007-s11481-013-9485-1/

23/01/2015 www.pdf-archive.com

Mitchell P2D2 48%

They can suppress or activate the release of proinflammatory agents, like cytokines, nitric oxide (NO), and neurotrophic factors11-13, in response to contact with immunogens and neurotransmitters10,12.

https://www.pdf-archive.com/2016/04/20/mitchell-p2d2/

20/04/2016 www.pdf-archive.com

Summary of Research 44%

The consequence is mass non-specific T cell proliferation which subsequently release copious quantities of pro-inflammatory cytokines (particularly IFN-γ, and TNF-α) into the circulation (Sriskandan and Reglinski, 2017) (fig.

https://www.pdf-archive.com/2017/07/03/summary-of-research/

03/07/2017 www.pdf-archive.com

top-selling-kits-2016 44%

High Stability Full Range of Products Efficient Delivery Reliable Supply Chain Perfect Technical Support and After-sale Service Application areas Hormone Respiratory system Cytokines &

https://www.pdf-archive.com/2016/07/08/top-selling-kits-2016/

08/07/2016 www.pdf-archive.com

AP test #1 outline #3 41%

Required Reading: Capriotti, Theresa, Parker Fizzell, Joan (2016).

https://www.pdf-archive.com/2020/01/26/ap-test-1-outline-3/

26/01/2020 www.pdf-archive.com

Official Event Guide ICI Europe 06.11.18 38%

Interrogating the Tumor, its Microenvironment, and Neoantigens with ACE ImmunoID • Introduce ACE ImmunoID as a universal platform for immuno-oncology and rational combination therapy development • Overcoming common NGS challenges from poor sample quality and quantity, to sequencing gaps, for more precise and complete genomic data • Facilitating comprehensive tumor immunogenomic characterization with integrated analytics for neoantigens, HLA, immunomodulators, adaptive and innate immunity, cytokines and chemokines, cytotoxicity, and mechanisms of tumor escape Erin Newburn Associate Director, Field Applications Scientist Personalis 10.00 Speed Networking &

https://www.pdf-archive.com/2018/11/12/officialeventguideicieurope061118/

12/11/2018 www.pdf-archive.com